Purchase Order HT940822P0007
Award Date 9/13/22
Potential Completion Date 10/12/22
Potential Value $91K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
- The federal contract award is to STEMCELL TECHNOLOGIES INC, a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $9,963.30 firm fixed price contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call, which is part of a larger $10,000,000 BPA vehicle that enables STEMCELL TECHNOLOGIES INC...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $7,131.73 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for T-cell isolation products needed for research in Dr. Kemper's lab. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a Canadian biotechnology company, to purchase a RoboSep-S automated cell separation system with a 5-year warranty and maintenance service. The contract, valued at $94,612.00, does not have a small business set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian parent...
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
- This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer, a civilian agency, to Stemcell Technologies Inc., a for-profit Canadian biotechnology company. The contract, valued at $14,677.50, is for the provision of maintenance services for Stemcell Technologies' proprietary research tools and supplies. Stemcell Technologies Inc. is the prime contractor and there is no indication of any major subcontractors. The contract is not set aside for small...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence. The $4,828.50 firm fixed-price contract was issued as a Blanket Purchase Agreement (BPA) call, without any set-aside designation. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- STEMCELL Technologies Inc., a subsidiary of the Canadian parent company STEMCELL Technologies, received a $11,943 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on June 8, 2022. This was a Blanket Purchase Agreement (BPA) call representing a repeat order for specialized cell isolation and enrichment products, specifically an EasySep Human Pan-B Cell Enrichment Kit and custom human isolation kit components featuring CD86...